All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Discussion Group Report
Nazneen Dewji, President and CEO of Cenna Biosciences leads a discussion on the strategies to overcome the challenges ‘Oral Delivery of Peptides’.
Edited by Tia Byer |
24 June 2022
Peptides
Commentary
In this Commentary article, we explore how innovative technologies like expression tags could help to overcome challenges associated with recombinant peptide production. The potential for recombinant production to slash manufacturing costs has made it a focal area of research for companies such as Boehringer Ingelheim.
17 May 2022
Peptides
Insight Article
UCB, Bicycle Therapeutics, and Sanofi share their latest findings in Peptide discovery at Biologics UK 2022.
Edited by Tia Byer |
10 May 2022
Peptides
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our January Discussion Group addressing ‘Peptides Green Chemistry Strategies and Methods’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
Edited by Tia Byer |
25 February 2022
Peptides
Insight Article
In this Insight Article, we explore the future possibilities, challenges, and solutions in peptide purification and the delivery of precision medicine for immunotherapy.
Edited by Tia Byer |
14 January 2022
Peptides
Post-Event Report
What are the key market trends and challenges facing the Peptides therapeutic industry today? We sat down with an advisory group of leading pharmaceutical and academic experts to discuss our latest Peptides Congress and the interesting insights it disclosed.
Edited by Tia Byer |
12 January 2022
Peptides
Written Q&A
Strides made in a landmark phase IIb oral insulin clinical trial.
Edited by Tom Cohen |
03 January 2022
Peptides
Commentary
Can AI-driven peptide purification advance the therapeutic capabilities of peptide drugs? Principal Scientist at Novo Nordisk, Jacob Kofoed takes us through their high-throughput peptide synthesis and purification platform and its promise to do just that.
Edited by Tia Byer |
01 October 2021
Peptides
Audio Content
Podcast
In Conversation With David Brayden, Professor of Advanced Drug Delivery, University College Dublin
17 August 2021
Peptides
Audio Content
Podcast
In Conversation With Volker Derdau, Section Head, Isotope Chemistry, Sanofi
15 August 2021
Peptides

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login